U.S. imports of Rutoside (Rutin) and Its Derivatives (HS 293810) totaled $366K in August 2026, imported from 7 countries.
Importers of Rutoside (Rutin) and Its Derivatives paid $44K in duties in August 2026, an average duty rate of 11.98% — duty actually collected as a share of the imports that cleared customs, not the published tariff schedule. Rutoside (Rutin) and Its Derivatives imports of $366K in August 2026 ran 35% below the year-to-date monthly average of $565K.
Last updated: August 2026 dataRutin is a flavonoid glycoside — quercetin-3-rutinoside — extracted primarily from buckwheat, sophora japonica buds, and other plant sources, and it trades as both a pharmaceutical intermediate and a nutraceutical ingredient used for capillary-fragility indications. China dominates US supply by a wide margin, with Spain and Brazil as secondary sources, reflecting the geographic concentration of buckwheat and sophora cultivation and extraction capacity. Imports intended for pharmaceutical use require FDA admissibility review, while nutraceutical-grade material may enter under dietary supplement regulations with different documentation requirements — making the intended end-use a critical factor in entry planning.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
12 import shipments a month
Pharmaceutical-grade rutin entering as an API must come from an FDA-registered facility and be supported by a Drug Master File or equivalent documentation. Nutraceutical or dietary-supplement-grade rutin is regulated under DSHEA and does not require the same pre-market approval, but the importer of record bears responsibility for ensuring the product meets identity, purity, and labeling standards. Misclassifying pharmaceutical-grade material as a supplement — or vice versa — can result in FDA detention. Consult a licensed customs broker or regulatory counsel for admissibility guidance.
Both natural (plant-extracted) and synthetic rutin and its derivatives classify under heading 2938 as glycosides, with the specific 10-digit line (2938100000) covering the full scope. The extraction or synthesis route does not change the classification, but it may affect FDA regulatory pathway and quality specifications. Importers should confirm the source and processing method in supplier documentation to support both classification and admissibility review.
ImportsExports
Imports
$366KYoY · free account
Exports
$17KYoY · free account
12-mo low · imports
Low · free accountOver the twelve months to August 2026, the U.S. imported $7.5M of Rutoside (Rutin) and Its Derivatives and exported $680K.
Fewer than 6 of the last 12 months reported trade, or the latest month was under $500K; the trend chart is not shown for thin series.
Through August 2026 · exports 11 of 12 months reported. Source: U.S. Census Bureau.
Subheading 2 of 2 in heading 2938
Subheading 293810 · $366K of $22.1M
Trade Directory
List your company under HS 293810 — Rutoside (Rutin) and Its Derivatives, so the companies trading it can find you. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Imports for consumption | Average duty rate | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 2938100000 | Rutoside (Rutin) and Its Derivatives) | $366K | 11.98% | 100.00% | $44K |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 2938100000 | Rutoside (Rutin) and Its Derivatives) | $17K |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
Imports · August 2026
origin
China and Spain together supply 99% of it.
customs district
destination
entry
rate provision · imports
duty collected equals 11.98% of imports for consumption.